Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 9(R) Hydrogenated 1 Deoxypaclitaxel. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102558105A discloses a novel semi-synthetic route for taxol analogs using abundant 1-dehydroxybaccatin VI. This method improves solubility and reduces multidrug resistance.